SENNA
- Manufacturer
- RITE AID | TIME CAP LABORATORIES, INC.
- Effective date
- 2021-11-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 23:44:37
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Sennosides 8.6 mg
OTC - PURPOSE SECTION
Purpose
Laxative
INDICATIONS & USAGE SECTION
Uses
- relieves occasional constipation (irregularity)
- generally causes bowel movement in 6-12 hours
WARNINGS SECTION
Warnings
OTC - DO NOT USE SECTION
Do not use
laxative products for longer than 1 week unless directed by a doctor
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel movements that continues over a period of 2 weeks
OTC - STOP USE SECTION
Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of laxative. These may indicate a serious condition.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- take preferably at bedtime or as directed by a doctor
- if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease dose until you are comfortable
| age | starting dosage | maximum dosage |
| adults and children 12 years and over | 2 tablets once a day | 4 tablets twice a day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
OTHER SAFETY INFORMATION
Other information
- each tablet contains: calcium 25 mg, sodium 2 mg (VERY LOW SODIUM)
- store at 25°C (77°F) excursions permitted between 15°-30°C (59°-86°F)
INACTIVE INGREDIENT SECTION
Inactive ingredients croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil
OTC - QUESTIONS SECTION
Questions or comments? Call 1-877-290-4008
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 11822-7851-8 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-aed3-d83d-e063-dadaa90ab31f | 191R RITE AID 11822 7851 NATURAL LAXATIVE 500 CT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11822-7851-8 | SENNA | 500 in 1 BOTTLE, PLASTIC | TABLET, COATED | 500 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11822-7851 | SENNA (SENNOSIDES) TABLET, COATED [RITE AID] | 2 | Legacy NDC, 1 package rows | 20211102_ad5086eb-97d3-300a-e053-2a95a90a15cc.zip |
Products#
Every source-derived product name is available through these pages.
- SENNA
- SENNOSIDES
- CROSCARMELLOSE SODIUM
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE
- HYPROMELLOSES
- MAGNESIUM STEARATE
- CELLULOSE, MICROCRYSTALLINE
- MINERAL OIL
- SENNOSIDES A AND B
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11822-7851 | 11822-7851-8 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| SENNOSIDES A AND B | 1B5FPI42EN | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cf6a35bb-7746-4bbe-e053-2a95a90a6fac | ad5086eb-97d3-300a-e053-2a95a90a15cc | 2021-11-01 | Warnings | cf6a35bb-7746-4bbe-e053-2a95a90a6fac ad5086eb-97d3-300a-e053-2a95a90a15cc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
